Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Apr 01, 2020 10:41AM
|
Re: guesses as to when our partner(s)/deal will be announced?
|
1
|
Resverlogix Corp.
|
Aug 21, 2020 04:14PM
|
Re: what are the chances?
|
1
|
Resverlogix Corp.
|
Mar 24, 2022 07:15PM
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 11, 2021 09:14AM
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
1
|
Resverlogix Corp.
|
Mar 24, 2020 09:54AM
|
Re: Don, don't stretch this out too long! Just remember, this can get a lot worse in the Fall!
|
1
|
Resverlogix Corp.
|
Jun 11, 2020 04:58PM
|
Re: today's trading
|
1
|
Resverlogix Corp.
|
Nov 18, 2020 02:03PM
|
Re: HL USA - Material or not?
|
1
|
Resverlogix Corp.
|
Apr 11, 2019 03:28PM
|
Re: Level 2 Quotes this morning
|
1
|
Resverlogix Corp.
|
Jun 16, 2022 03:18PM
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
1
|
Resverlogix Corp.
|
Jun 15, 2019 09:11AM
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 10:49AM
|
Re: Will Hepalink make a move for RVX?
|
1
|
Resverlogix Corp.
|
Jul 15, 2020 08:18AM
|
Re: December 22, 2020.
|
1
|
Resverlogix Corp.
|
Oct 10, 2020 07:10PM
|
Re: Trading
|
1
|
Zenith Epigenetics
|
Sep 20, 2022 02:03PM
|
Re: Trial delay
|
1
|
Resverlogix Corp.
|
May 04, 2021 06:01PM
|
Re: Canadian Securities Administrators
|
1
|
Resverlogix Corp.
|
May 15, 2024 09:41AM
|
Re: CKD Reata / Market Cap
|
1
|
Resverlogix Corp.
|
May 05, 2019 11:22AM
|
Re: Sent this to IR this morning,...
|
1
|
Resverlogix Corp.
|
Dec 13, 2019 10:24AM
|
Re: HL USA - Material or not?
|
1
|
Resverlogix Corp.
|
Apr 11, 2019 03:38PM
|
Re: What we know and what we don't.....
|
1
|
Resverlogix Corp.
|
May 16, 2019 02:23PM
|